Header cover image

Dutch (AEX) Biotech Industry Analysis

UpdatedJun 04, 2026
DataAggregated Company Financials
Companies3
  • 7D-5.6%
  • 3M-19.7%
  • 1Y-5.9%
  • YTD-20.7%

Over the last 7 days, the Biotech industry has dropped 3.6%, driven by pullbacks from every company within the industry. Overall the industry is down 4.3% in 12 months. As for the next few years, earnings are forecast to decline by 20% per annum.

Industry Valuation and Performance

Has the Dutch Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 04 Jun 2026€2.3b€1.4b€489.7m36.6x4.7x1.7x
Sat, 02 May 2026€2.6b€1.4b€313.1m210.4x8.4x1.8x
Mon, 30 Mar 2026€2.7b€1.4b€309.5m199.5x8.7x1.9x
Wed, 25 Feb 2026€3.0b€1.4b€307.3m1520.8x9.7x2.1x
Fri, 23 Jan 2026€3.1b€595.4m-€456,029,688.803559.4x-6.9x5.3x
Sun, 21 Dec 2025€2.8b€596.3m-€456,028,733.802944.2x-6.2x4.7x
Tue, 18 Nov 2025€2.8b€599.3m-€456,025,639.602895.7x-6x4.6x
Thu, 16 Oct 2025€2.8b€567.6m-€307,976,440.00n/a-9.1x5x
Sat, 13 Sep 2025€2.7b€565.2m-€307,918,220.00n/a-8.7x4.7x
Mon, 11 Aug 2025€2.6b€567.5m-€316,059,980.00n/a-8.2x4.6x
Wed, 09 Jul 2025€2.3b€561.8m-€211,943,536.00n/a-10.7x4x
Fri, 06 Jun 2025€2.4b€568.6m-€212,244,121.60n/a-11.1x4.1x
Sun, 04 May 2025€2.2b€551.1m-€210,379,364.50n/a-10.4x4x
Tue, 01 Apr 2025€2.1b€550.4m-€11,474,256.10n/a-179.7x3.7x
Thu, 27 Feb 2025€2.3b€547.4m-€18,235,237.60n/a-124.7x4.2x
Sat, 25 Jan 2025€2.1b€531.9m-€77,566,019.90n/a-26.9x3.9x
Mon, 23 Dec 2024€2.3b€534.0m-€77,692,563.20n/a-29.4x4.3x
Wed, 20 Nov 2024€2.2b€529.8m-€77,432,347.40n/a-28.1x4.1x
Fri, 18 Oct 2024€2.4b€517.7m€19.2m58.3x123.8x4.6x
Sun, 15 Sep 2024€2.3b€512.0m€19.5m56.1x115.6x4.4x
Tue, 13 Aug 2024€2.0b€515.3m€19.3m46.9x101.5x3.8x
Thu, 11 Jul 2024€2.1b€482.2m€20.7m52.7x103.4x4.4x
Sat, 08 Jun 2024€2.2b€482.6m€20.7m53.3x104.7x4.5x
Mon, 06 May 2024€2.4b€471.5m€20.9m57.9x114x5.1x
Wed, 03 Apr 2024€2.6b€467.5m-€39,674,515.30n/a-66.5x5.6x
Fri, 01 Mar 2024€3.1b€442.1m-€50,694,286.00n/a-60.8x7x
Sun, 28 Jan 2024€3.3b€745.5m-€199,675,066.00n/a-16.7x4.5x
Tue, 26 Dec 2023€3.3b€742.6m-€199,383,940.00n/a-16.6x4.5x
Thu, 23 Nov 2023€3.2b€745.2m-€199,650,806.00n/a-15.9x4.2x
Sat, 21 Oct 2023€3.1b€754.9m-€199,132,592.00n/a-15.4x4x
Mon, 18 Sep 2023€3.4b€753.7m-€199,034,084.00n/a-17.1x4.5x
Wed, 16 Aug 2023€3.4b€748.9m-€200,523,470.00n/a-16.9x4.5x
Fri, 14 Jul 2023€3.5b€727.3m-€211,407,146.00n/a-16.5x4.8x
Sun, 11 Jun 2023€3.7b€735.4m-€211,486,946.00n/a-17.5x5x
Price to Earnings Ratio

-17.5x


Total Market Cap: €3.7bTotal Earnings: -€211,486,946.00Total Revenue: €735.4mTotal Market Cap vs Earnings and Revenue0%0%0%
Dutch Biotech Industry Price to Earnings3Y Average -4.9x202420252026
Current Industry PE
    There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 23% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Dutch Healthcare industry?

NL Market1.86%
Healthcare-4.87%
Biotech-5.61%
Biotech-5.61%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News